NuScale Power Corporation (SMR) short interest & options flow
NYSENuScale Power faces intensifying skepticism from Wall Street as Barclays analyst Christine Cho downgraded the small modular reactor developer to Underweight and cut her price target 55% to $5, now implying 12% downside from current levels. The downgrade marks the second major analyst capitulation in six weeks, following UBS's September cut to Sell. Consensus remains "hold" at $11.37, but downward revisions dominate: eight of the last ten analyst moves have lowered targets. SMR shares have tumbled 31% in one month and 60% year-to-date, yet short interest remains elevated at 28% of float, suggesting persistent bearish conviction despite the dramatic sell-off.
SMR Barclays slashes target to $5 from $11, downgrades to Underweight.
NuScale Power faces intensifying skepticism from Wall Street as Barclays analyst Christine Cho downgraded the small modular reactor developer to Underweight and cut her price target 55% to $5, now implying 12% downside from current levels. The downgrade marks the second major analyst capitulation in six weeks, following UBS's September cut to Sell. Consensus remains "hold" at $11.37, but downward revisions dominate: eight of the last ten analyst moves have lowered targets. SMR shares have tumbled 31% in one month and 60% year-to-date, yet short interest remains elevated at 28% of float, suggesting persistent bearish conviction despite the dramatic sell-off.
- Market cap
- $2.11B
- Next earnings
- 5 Nov 2026
Key data as of 5 Nov 2026
Latest signals on SMR
- Analyst
SMR Barclays slashes target to $5 from $11, downgrades to Underweight.
SMR news and analysis
RSSNo long-form analysis yet for SMR. Pulse alerts and the live data picture are available on ORTEX.
Open SMR on ORTEX →Want the live picture for SMR?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SMR — free to start on ORTEX.
Sign up for free →Open SMR on ORTEX